• Tumour-derived• Contains 30% collagen IV, 8% entactin, perlecan, transforming growth factor, epidermal growth factor, insulin-like growth factor, tissue plasminogen activator, and residual matrix metalloproteinases• 8–21 mg of protein/mL. This evidence concerns the gene HSPG2 and neoplasm.